CCS
STML

Crosspoint Capital Strategies’s Stemline Therapeutics, Inc. STML Stock Holding History

Crosspoint Capital Strategies’s Portfolio STML Stock Details STML Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-6,600
Closed -$1.03M – 111
2017
Q4 		$1.03M Hold
6,600
– – 0.09% 42
2017
Q3 		$73K Hold
6,600
– – 0.06% 47
2017
Q2 		$61K Buy
+6,600
New +$61K 0.05% 54